Polymer-drug conjugates: Recent development in clinical oncology
Top Cited Papers
- 8 February 2008
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (8) , 886-898
- https://doi.org/10.1016/j.addr.2007.11.009
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid MalignanciesClinical Cancer Research, 2007
- A Novel Method for Imaging In Vivo Degradation of Poly(L-Glutamic Acid), a Biodegradable Drug CarrierPharmaceutical Research, 2007
- Magnetic Resonance Imaging of Therapy-Induced Necrosis Using Gadolinium-Chelated Polyglutamic AcidsInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsInvestigational New Drugs, 2007
- Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and LymphomasClinical Cancer Research, 2005
- Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid TumorsCancer Investigation, 2005
- PEG drugs: an overviewJournal of Controlled Release, 2001
- Potentiation of radioresponse by polymer–drug conjugatesJournal of Controlled Release, 2001
- Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers a potential drug delivery systemBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975